Stanford, California 94305

  • Hodgkin

Purpose:

To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.


Study summary:

To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells. The researchers hope to learn whether or not this will be more effective in removing the tumor cells as compared to other methods of purging (the removal of cancer cells).


Criteria:

Inclusion Criteria:- relapsed NHL Exclusion Criteria:- liver dysfunction


NCT ID:

NCT00186355


Primary Contact:

Principal Investigator
Robert S Negrin
Stanford University


Backup Contact:

N/A


Location Contact:

Stanford, California 94305
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.